David Silberman - 03 Jan 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role: Chief Financial Officer
Signature: /s/ David Silberman
Issuer symbol: ORMP
Transactions as of: 03 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 05 Jan 2022, 19:32:00 UTC
Previous filing: 02 Sep 2021
Next filing: 01 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORMP	Common Stock	Award		+19,000	+38%		69,000	03 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORMP	Stock Option (right to buy)	Award	$0	+32,000		$0.000000	32,000	03 Jan 2022	Common Stock	32,000	$13.89	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 4,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2	The Stock Option will vest in 4 installments as follows: 8,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.